Use of estradiol valerate in women with thin endometrium in ART cycles
https://doi.org/10.21518/ms2025-335
Abstract
Introduction. Patients with infertility often require the help of assisted reproductive technologies to solve their problem. Two thirds of failures in ART cycles are associated with insufficient endometrial receptivity.
Aim. To evaluate the effectiveness of using estradiol valerate 2 mg (Progynova®) in women with thin endometrium in ART cycles.
Materials and methods. The study included patients with a thin endometrium ≤ 7.0 mm according to the ultrasound examination (US) of the pelvic organs on the 10–14th day of the menstrual cycle (peak of luteinizing hormone (LH) in the blood or on the day of progesterone administration in the hormone replacement therapy cycle). Patients with a thin endometrium (n = 74) were divided into two groups: the first group (n = 43) – patients with chronic endometritis established by histological examination and immunohistochemistry (IHC); group 2 (n=31) – patients with a thin endometrium without chronic endometritis. All patients received estradiol valerate according to one of the following regimens: 4 mg estradiol valerate in a natural cycle from the moment the dominant follicle reached a diameter of 13 mm or 4 mg estradiol valerate from day 3 of the menstrual cycle.
Results. Administration of estradiol valerate statistically significantly increased the endometrial thickness in women with thin endometrium (p < 0.05). The increase in endometrial thickness in patients of group 1 averaged 1.9279 mm, in patients of group 2 – 2.09 mm. The average endometrial thickness before treatment with estradiol valerate was 6.315 (4.7; 7.0) mm, after treatment – 8.311 (5.6; 11.0). 70 of 74 (94.6%) patients had an endometrial thickness of > 7 mm. Pregnancy in an IVF or PE cycle occurred in 44 patients with thin endometrium (62.5%) after treatment with estradiol valerate.
Conclusions. The use of estradiol valerate in IVF and ET cycles increases the thickness of the endometrium and increases the frequency of pregnancy and live birth in patients with a thin endometrium.
About the Authors
A. V. SolovyevaRussian Federation
Alina V. Solovyeva, Dr. Sci. (Med.), Professor at the Department of Obstetrics and Gynecology with the course of Perinatology
6, Miklukho-Maklai St., Moscow, 117198
K. S. Ermolenko
Russian Federation
Kristina S. Ermolenko, Cand. Sci. (Med.), Deputy Chief Physician
23, Bldg. 2, Bolshaya Novodmitrovskaya St., Moscow, 127015
L. T. Kulumbegova
Russian Federation
Leyla T. Kulumbegova, Cand. Sci. (Med.), Chief Physician
23, Bldg. 2, Bolshaya Novodmitrovskaya St., Moscow, 127015
D. S. Mamchich
Russian Federation
Daria S. Mamchich, Resident of the Department of Obstetrics and Gynecology with the course of Perinatology
6, Miklukho-Maklai St., Moscow, 117198
M. A. Spitsyna
Russian Federation
Maria A. Spitsyna, Postgraduate Student of the Department of Obstetrics and Gynecology with the course of Perinatology
6, Miklukho-Maklai St., Moscow, 117198
References
1. Sehring J, Beltsos A, Jeelani R. Human implantation: The complex interplay between endometrial receptivity, inflammation, and the microbiome. Placenta. 2022;117:179–186. https://doi.org/10.1016/j.placenta.2021.12.015.
2. Vilella F, Wang W, Moreno I, Quake SR, Simon C. Understanding the human endometrium in the 21 st century. Am J Obstet Gynecol. 2021;225(1):1–2. https://doi.org/10.1016/j.ajog.2021.04.224.
3. Motovilova ТМ, Simakova VYu, Kazakova KV, Kazarinova DA. Modern concepts about the problem of endometrial infertility against the backdrop of the “thin endometrium” (literature review). Consilium Medicum. 2024;26(7):403–410. (In Russ.) https://doi.org/10.26442/20751753.2024.7.202891.
4. Ata B, Mathyk B, Telek S, Kalafat E. Walking on thin endometrium. Curr Opin Obstet Gynecol. 2024;36(3):186–191. https://doi.org/10.1097/GCO.0000000000000948.
5. Liu KE, Hartman M, Hartman A. Management of thin endometrium in assisted reproduction: a clinical practice guideline from the Canadian Fertility and Andrology Society. Reprod Biomed Online. 2019;39(1):49–62. https://doi.org/10.1016/j.rbmo.2019.02.013.
6. Wu J, Huang J, Dong J, Xiao X, Li M, Wang X. The thicker the endometrium, the better the neonatal outcomes? Hum Reprod Open. 2023;2023(3):hoad028. https://doi.org/10.1093/hropen/hoad028.
7. Zheng Y, Chen B, Dai J, Xu B, Ai J, Jin L, Dong X. Thin endometrium is associated with higher risks of preterm birth and low birth weight after frozen single blastocyst transfer. Front Endocrinol. 2022;13:1040140. https://doi.org/10.3389/fendo.2022.1040140.
8. Oron G, Hiersch L, Rona S, Prag-Rosenberg R, Sapir O, Tuttnauer-Hamburger M et al. Endometrial thickness of less than 7.5 mm is associated with obstetric complications in fresh IVF cycles: a retrospective cohort study. Reprod Biomed Online. 2018;37(3):341–348. https://doi.org/10.1016/j.rbmo.2018.05.013.
9. Orazov MR, Radzinskij VE, Khamoshina MB, Kaygorodova LA, Toktar LR, Pokul LV, Tulupova MS. “Thin” endometrium – modern view of the problem. Farmateka. 2018:(6):15–22. (In Russ.) https://doi.org/10.18565/pharmateca.2018.6.15-22.
10. Mahutte N, Hartman M, Meng L, Lanes A, Luo ZC, Liu KE. Optimal endometrial thickness in fresh and frozenthaw in vitro fertilization cycles: an analysis of live birth rates from 96,000 autologous embryo transfers. Fertil Steril. 2022;117(4):792–800. https://doi.org/10.1016/j.fertnstert.2021.12.025.
11. Mathyk B, Schwartz A, DeCherney A, Ata B. A critical appraisal of studies on endometrial thickness and embryo transfer outcome. Reprod Biomed Online. 2023;47(4):103259. https://doi.org/10.1016/j.rbmo.2023.103259.
12. Wang Y, Tang Z, Teng X. New advances in the treatment of thin endometrium. Front Endocrinol. 2024;15:1269382. https://doi.org/10.3389/fendo.2024.1269382.
13. Lv H, Zhao G, Jiang P, Wang H, Wang Z, Yao S et al. Deciphering the endometrial niche of human thin endometrium at single-cell resolution. Proc Natl Acad Sci U S A. 2022;119(8):e2115912119. https://doi.org/10.1073/pnas.2115912119.
14. Chemerinski A, Garcia de Paredes J, Blackledge K, Douglas N, Morelli S. Mechanisms of endometrial aging: lessons from natural conceptions and assisted reproductive technology cycles. Front Physiol. 2024;15:1332946. https://doi.org/10.3389/fphys.2024.1332946.
15. Liu SM, Zhou YZ, Wang HB, Sun ZY, Zhen JR, Shen K et al. Factors Associated with Effectiveness of Treatment and Reproductive Outcomes in Patients with Thin Endometrium Undergoing Estrogen Treatment. Chin Med J. 2015;128(23):3173–3177. https://doi.org/10.4103/0366-6999.170258.
16. Shaodi Z, Qiuyuan L, Yisha Y, Cuilian Z. The effect of endometrial thickness on pregnancy outcomes of frozenthawed embryo transfer cycles which underwent hormone replacement therapy. PLoS ONE. 2020;15(9):e0239120. https://doi.org/10.1371/journal.pone.0239120.
17. Liu KE, Hartman M, Hartman A, Luo ZC, Mahutte N. The impact of a thin endometrial lining on fresh and frozenthaw IVF outcomes: an analysis of over 40 000 embryo transfers. Hum Reprod. 2018;33(10):1883–1888. https://doi.org/10.1093/humrep/dey281.
Review
For citations:
Solovyeva AV, Ermolenko KS, Kulumbegova LT, Mamchich DS, Spitsyna MA. Use of estradiol valerate in women with thin endometrium in ART cycles. Meditsinskiy sovet = Medical Council. (In Russ.) https://doi.org/10.21518/ms2025-335